NAPLES, Fla.,
Sept. 9, 2021 /PRNewswire/
-- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or
the "Company"), a patient-first biotechnology company developing
novel cannabinoid medicines to improve quality of life for cancer
patients, today announced that Dr. Joseph Tucker, MagicMed
Industries' ("MagicMed") Chief Executive Officer, is scheduled to
present at the H.C. Wainwright 23rd Annual Global
Investment Conference and Virtual Gravitas Health Reimagined
Investor Day.
Dr. Tucker's H.C. Wainwright 23rd Annual Global
Investment Conference presentation will be available on-demand
beginning Monday, September
13th at 7:00 a.m.
ET. To attend please register here.
Dr. Tucker is also scheduled to present on Thursday, September 16th at
10:00 a.m. PT / 1:00 p.m. ET at the Virtual Gravitas Health
Reimagined Investor Day. To register for the event please use the
following LINK.
On May 24, 2021, Enveric
Biosciences announced the definitive agreement to acquire
MagicMed Industries. Enveric and MagicMed will each hold a meeting
of their respective stockholders. The Enveric annual meeting will
be held virtually on September 14,
2021 at 10:00 a.m., Eastern
Time, at www.virtualshareholdermeeting.com/ENVB2021.
For more information about each conference or to schedule a
one-on-one meeting with MagicMed's management team, please contact
your appropriate H.C. Wainwright or Gravitas representative
directly, or KCSA Strategic Communications at
EnvericBio@kcsa.com.
About the H.C. Wainwright 23rd Annual Global
Investment Conference
H.C. Wainwright & Co. is hosting its 23rd Annual Global
Investment Conference, which is being held as a virtual event from
September 13-15, 2021. A
record-setting number of participants are expected to view the 850+
company presentations scheduled as live feed or available as
recorded for this year's edition of the H.C. Wainwright Global
Investment Conference.
The conference offers six sector tracks devoted to Healthcare
& Biotech, Metals & Mining, Cryptocurrency, Blockchain
& FinTech, CleanTech, Technology, Media &
Telecommunications and Shipping & Maritime.
The daily format includes corporate presentations, investor
one-on-one meetings, topical presentations by keynote speakers and
virtual evening events to encourage informal interaction amongst
conference participants. The annual conference is a "must see"
event for institutional investors of all types, private equity
firms, venture capitalists, industry executives and business
development executives.
About the Gravitas Health Reimagined Investor Day
This
year's Gravitas Health Reimagined Investor Day will feature several
leaders in the healthcare space and will be attended virtually by
institutional and retail investors from North America and abroad. For additional
details about the conference and Gravitas Securities Inc., please
visit: www.gravitassecurities.com
About Enveric Biosciences
Enveric Biosciences is a
patient-first biotechnology company developing rigorously tested,
novel cannabinoid medicines to improve quality of life for cancer
patients. Initial indications include radiodermatitis, a common and
often severe side effect of radiation therapy, and
chemotherapy-induced neuropathy. For more information, please visit
https://www.enveric.com/.
About MagicMed
MagicMed Industries intends to partner
with pharmaceutical and other companies to develop and
commercialize psychedelic-derived pharmaceutical candidates.
MagicMed's psychedelic derivatives library, the Psybrary™, is
anticipated to be an essential building block from which industry
can develop new patented products. The initial focus of the
Psybrary™ is on psilocybin and DMT derivatives, and it is then
expected to be expanded to other psychedelics such as MDMA, LSD,
mescaline, and ibogaine. For more information,
please visit https://www.magicmedindustries.com/.
Investor Contacts
Valter
Pinto / Allison Soss
KCSA Strategic Communications
212.896.1254 / 212.896.1267
valter@kcsa.com / asoss@kcsa.com
Media Contacts
Caitlin
Kasunich / Raquel Cona
KCSA Strategic Communications
212.896.1241 / 212.896.1204
ckasunich@kcsa.com / rcona@kcsa.com
MagicMed Industries Contact
Natalie Dolphin
Director of Marketing
ndolphin@magicmedindustries.com
View original
content:https://www.prnewswire.com/news-releases/enveric-biosciences-announces-magicmed-industries-presentations-at-the-following-investor-conferences-in-september-301371997.html
SOURCE Enveric Biosciences